Cargando…

Response to “Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis”

Detalles Bibliográficos
Autores principales:	Patel, Jignesh P., Thavarajah, Vassan, Roberts, Lara N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238255/ https://www.ncbi.nlm.nih.gov/pubmed/37274175 http://dx.doi.org/10.1016/j.rpth.2023.100172

Ejemplares similares

Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2023)

Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
por: Watras, Magdalena M., et al.
Publicado: (2016)

The “lived” experience of menstruating women commencing anticoagulants
por: Sheikh, Umber, et al.
Publicado: (2023)

How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study
por: Patel, Jignesh P., et al.
Publicado: (2023)

Anticoagulated patient’s perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy – study protocol for The Switching Study: a prospective cohort study
por: Auyeung, Vivian, et al.
Publicado: (2016)

Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
por: van den Boom, Bente P., et al.
Publicado: (2021)

Fungal Infection in Acutely Decompensated Cirrhosis Patients: Value of Model for End-Stage Liver Disease Score
por: Habib, Shahid, et al.
Publicado: (2020)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

Protective role of melatonin in early‐stage and end‐stage liver cirrhosis
por: Hu, Chenxia, et al.
Publicado: (2019)

Anticoagulation in cirrhosis: a new paradigm?
por: Leonardi, Filippo, et al.
Publicado: (2017)

Elevated International Normalized Ratio Due to Apixaban in Patient With End-Stage Renal Disease on Hemodialysis
por: Kahlon, Navkirat, et al.
Publicado: (2022)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
por: Gallagher, Celine, et al.
Publicado: (2019)

International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy
por: Hu, Xiao-Peng, et al.
Publicado: (2019)

The predictive value of blood neutrophil-lymphocyte ratio in patients with end-stage liver cirrhosis following ABO-incompatible liver transplantation
por: Lin, Bingyi, et al.
Publicado: (2016)

Slightly elevated international normalized ratio predicts bleeding episodes in patients treated with direct oral anticoagulants
por: Bhardwaj, Priya, et al.
Publicado: (2020)

Automated calculation of coagulation activity and International Normalized Ratio in oral anticoagulant control
por: Peters, R. H. M., et al.
Publicado: (1987)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?
por: Protopapas, Adonis A., et al.
Publicado: (2023)

Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis
por: Emenena, Isioma, et al.
Publicado: (2023)

Factors influencing the recruitment of lactating women in a clinical trial involving direct oral anticoagulants: a qualitative study
por: Zhao, Yating, et al.
Publicado: (2018)

Managing direct oral anticoagulants in accordance with the Scottish Dental Clinical Effectiveness Programme guidance for patients undergoing dentoalveolar surgery
por: Woolcombe, Sarah A., et al.
Publicado: (2022)

Usefulness of International Normalized Ratio to Albumin Ratio for Evaluation of Mortality in Hepatitis B Virus-Associated Decompensated Cirrhosis
por: Cai, Ming, et al.
Publicado: (2021)

New prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2021)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis
por: Jarboe, Lindsey, et al.
Publicado: (2022)

Study of Gonadal Hormones in Males With Liver Cirrhosis and Its Correlation With Child-Turcotte-Pugh and Model for End-Stage Liver Disease Scores
por: Vaishnav, Bhumika, et al.
Publicado: (2023)

Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets
por: Simon, Tracey G, et al.
Publicado: (2023)

Patients with elevated international normalized ratio due to oral anticoagulants: An evaluation of risk factors
por: Koufakis, Theocharis, et al.
Publicado: (2015)

Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions
por: Tan, Juntao, et al.
Publicado: (2022)

Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
por: Kim, Ae Jin, et al.
Publicado: (2016)

Associations between illness beliefs, medication beliefs, anticoagulation‐related quality of life, and INR control: Insights from the Switching Study
por: Bartoli‐Abdou, John K., et al.
Publicado: (2018)

The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis
por: Chang, Wen Xiu, et al.
Publicado: (2016)

In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2018)

The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases
por: Yamasaki, Eiki, et al.
Publicado: (2022)

Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
por: Maretti-Mira, Ana C., et al.
Publicado: (2023)

Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis
por: Chen, Huan, et al.
Publicado: (2021)

Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis
por: Valeriani, Emanuele, et al.
Publicado: (2023)

Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
por: Goel, Narender, et al.
Publicado: (2020)

International Normalized Ratio Does Not Predict Gastrointestinal Bleeding After Endoscopic Retrograde Cholangiopancreatography in Patients With Cirrhosis
por: Adike, Abimbola, et al.
Publicado: (2017)

Prognostic Value of International Normalized Ratio in Ischemic Stroke Patients without Atrial Fibrillation or Anticoagulation Therapy
por: Xie, Xuewei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hb6ibqd92lm1sv7hlnlivqkijs